We invest in early-stage life-science companies with the potential to enhance human well-being and quality of life.
Continuing to
Grow & Invest
We are an evergreen fund that has a long-term investment perspective.
Focusing on the
Mid-Atlantic Region
We invest in life-science companies in the Mid-Atlantic region.
Launching Successful
Companies
Our portfolio companies have attracted over $4.2 billion of external capital to support their growth.
Latest News
AllAcuity PharmaceuticalsAlleviAlterisAnnovisAvid RadiopharmaceuticalsBainbridge HealthBioAdvance NewsCeptarisCohero HealthConcarlo TherapeuticsCrossBridgeEliksa TherapeuticsENB TherapeuticsGeneralHalo LabsHanimune TherapeuticsHealthQxImmunoGenesisImmunomeInfraScanInnervaceIntezyneiView TherapeuticsKaloCyteKayotheraKeritonLumenVuMebias DiscoveryMelior DiscoveryMidway PharmaceuticalsNovira TherapeuticsNuPatheOncora MedicalOnspira TherapeuticsOpsidioOssianixPalvella TherapeuticsPhrase HealthPillo HealthPortfolio NewsProtez PharmaceuticalsPSTRelmada TherapeuticsRenovacorRide HealthSenzoSIRPantStradosThe One Health CompanyTreventis CorporationVenatorx PharmaceuticalsVesteckVittoria Biotherapeutics